Ambu A/S (OTCMKTS:AMBBY) Sees Unusually-High Trading Volume – Should You Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw an uptick in trading volume on Wednesday . 700 shares changed hands during mid-day trading, an increase of 40% from the previous session’s volume of 500 shares.The stock last traded at $13.57 and had previously closed at $13.80.

Ambu A/S Price Performance

The company has a quick ratio of 1.63, a current ratio of 2.72 and a debt-to-equity ratio of 0.08. The company has a market cap of $3.19 billion, a price-to-earnings ratio of 39.91 and a beta of 0.94. The stock’s 50-day simple moving average is $13.55 and its 200 day simple moving average is $14.66.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 10.00% and a return on equity of 10.35%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.